In Situ Antigen-Generating Cancer Vaccine
AssigneePresident and Fellows of Harvard College
InventorsJaeyun Kim, David J. Mooney, Weiwei Aileen Li, Praveen Arany, Or Gadish
Life of this patent
Estimating the term…
Abstract
The invention provides compositions and methods for utilizing scaffolds in cancer vaccines.
Claims18
A biopsy-free method for producing a processed tumor antigen in situ comprising administering to a subject diagnosed with a cancer a porous 3-dimensional scaffold, said scaffold comprising a chemoattractant of cancer cells, maintaining said scaffold in situ for a time period sufficient to accumulate a circulating cancer cell to yield a cancer cell-containing scaffold, and contacting said cell-containing scaffold with a cytotoxic or cytolytic element to produce a processed tumor antigen.
A tumor antigen-processing device comprising a porous polymer, a chemoattractant for cancer cells, and a cytotoxicity-inducing composition.
Dependencies are inferred from the claim text.